Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet.

Valayannopoulos V, Bajolle F, Arnoux JB, Dubois S, Sannier N, Baussan C, Petit F, Labrune P, Rabier D, Ottolenghi C, Vassault A, Broissand C, Bonnet D, de Lonlay P.

Pediatr Res. 2011 Dec;70(6):638-41. doi: 10.1203/PDR.0b013e318232154f.

PMID:
21857385
2.

Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.

Dagli AI, Zori RT, McCune H, Ivsic T, Maisenbacher MK, Weinstein DA.

J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S103-6. doi: 10.1007/s10545-009-1088-x. Epub 2009 Mar 30.

3.

Nutrition therapy for hepatic glycogen storage diseases.

Goldberg T, Slonim AE.

J Am Diet Assoc. 1993 Dec;93(12):1423-30. Review.

PMID:
8245377
4.

Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy.

Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT.

Ann Intern Med. 1992 Jun 1;116(11):896-900.

PMID:
1580445
5.

A case of glycogen storage disease type III (glycogen debranching enzyme deficiency) with liver cirrhosis and hypertrophic cardiomyopathy.

Kobayashi A, Nishinomiya F, Fukamachi Y, Ohtaka M, Yamamoto J, Takagi K, Tanaka S, Takizawa S, Imadachi H, Fukase M, et al.

Tohoku J Exp Med. 1995 Jul;176(3):181-5.

6.

Diet therapy in severe clinical expression of debrancher deficiency.

Azael Meza A, Ayub M, Cantú JM, Flores J.

Arch Invest Med (Mex). 1991 Jul-Dec;22(3-4):285-8.

PMID:
1844114
7.

Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth.

Das AM, Lücke T, Meyer U, Hartmann H, Illsinger S.

Ann Nutr Metab. 2010;56(3):225-32. doi: 10.1159/000283242. Epub 2010 Mar 30.

PMID:
20357432
8.

An adult case of glycogen storage disease type IIIa.

Kim KO, Lee HJ, Choi JW, Eun JR, Choi JH.

Korean J Hepatol. 2008 Jun;14(2):219-25. doi: 10.3350/kjhep.2008.14.2.219.

PMID:
18617770
9.

Efficacy of cornstarch therapy in type III glycogen-storage disease.

Gremse DA, Bucuvalas JC, Balistreri WF.

Am J Clin Nutr. 1990 Oct;52(4):671-4.

PMID:
2403059
10.

Glycogen storage disease type III in Egyptian children: a single centre clinico-laboratory study.

El-Karaksy H, Anwar G, El-Raziky M, Mogahed E, Fateen E, Gouda A, El-Mougy F, El-Hennawy A.

Arab J Gastroenterol. 2014 Jun;15(2):63-7. doi: 10.1016/j.ajg.2014.01.013. Epub 2014 Feb 12.

PMID:
25097048
11.

Glycogen storage disease in adults.

Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, Chen YT, Crigler JF Jr, Ferreira P, Haworth JC, Herman GE, Issenman RM, Keating JP, Linde R, Roe TF, Senior B, Wolfsdorf JI.

Ann Intern Med. 1994 Feb 1;120(3):218-26. Review.

PMID:
8273986
12.

[Nine cases of debrancher deficiency (glycogen storage disease type III) presenting muscle weakness--study on clinicobiochemical analysis].

Fukuda T, Sugie H, Ito M, Tsurui S, Sugie Y, Igarashi Y.

Rinsho Shinkeigaku. 1996 Apr;36(4):540-3. Japanese.

PMID:
8810846
13.

Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group.

Haagsma EB, Smit GP, Niezen-Koning KE, Gouw AS, Meerman L, Slooff MJ.

Hepatology. 1997 Mar;25(3):537-40.

PMID:
9049194
14.

A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.

Kalkan Ucar S, Coker M, Sözmen E, Goksen Simsek D, Darcan S.

Nutr Metab Cardiovasc Dis. 2009 Jul;19(6):383-90. doi: 10.1016/j.numecd.2008.09.005. Epub 2008 Dec 13.

PMID:
19073362
15.

Hepatic glycogen storage disorders: what have we learned in recent years?

Burda P, Hochuli M.

Curr Opin Clin Nutr Metab Care. 2015 Jul;18(4):415-21. doi: 10.1097/MCO.0000000000000181. Review.

16.

Glycogen storage disease type IIIa presenting as non-ketotic hypoglycemia: use of a newly approved commercially available mutation analysis to non-invasively confirm the diagnosis.

Seigel J, Weinstein DA, Hillman R, Colbert B, Matthews B, Bachrach B.

J Pediatr Endocrinol Metab. 2008 Jun;21(6):587-90. Erratum in: J Pediatr Endocrinol Metab. 2009 Feb;22(2):191.

PMID:
18717245
17.

Glycogen storage disease type III with hypoketosis.

Clemente M, Gussinyer M, Arranz JA, Riudor E, Yeste D, Albisu M, Carrascosa A.

J Pediatr Endocrinol Metab. 2010 Aug;23(8):833-6.

PMID:
21073127
18.

Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III.

Brambilla A, Mannarino S, Pretese R, Gasperini S, Galimberti C, Parini R.

JIMD Rep. 2014;17:91-5. doi: 10.1007/8904_2014_343. Epub 2014 Oct 12.

19.

Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease.

Shaiu WL, Kishnani PS, Shen J, Liu HM, Chen YT.

Mol Genet Metab. 2000 Jan;69(1):16-23.

PMID:
10655153
20.

Glycogen storage disease type III in Inuit children.

Zimakas PJ, Rodd CJ.

CMAJ. 2005 Feb 1;172(3):355-8.

Supplemental Content

Support Center